The top 10 projected best-selling medications in 2026, including GLP-1 drugs and AbbVie's Skyrizi, have expected global sales reaching up to $31 billiion.

Tremfya (guselkumab) is a brand-name drug approved to treat ulcerative colitis (UC). This article covers topics such as side effects, dosage, and how Tremfya works. Tremfya is available as a ...

They’re usually injected or infused. A doctor may recommend biologics to treat ulcerative colitis (UC) if conventional medications do not help you achieve and maintain remission. When they’re ...

None of the immune-modulating drugs approved to treat ulcerative colitis – even biosimilars ... (tofacitinib), the only oral therapy on the list but one which has safety issues at higher ...

According to the National Institutes of Health, between 600,000 and 900,000 Americans have ulcerative colitis, a chronic ...

In patients with ulcerative colitis, vedolizumab outperformed infliximab as a second-line therapy following failure of ...